A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)

PHASE2TerminatedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

June 21, 2022

Primary Completion Date

January 22, 2024

Study Completion Date

January 22, 2024

Conditions
Diffuse Large B-cell Lymphoma
Interventions
DRUG

Loncastuximab Tesirine

Intravenous (IV) Infusion

DRUG

Rituximab

Cycle 1 - Intravenous (IV) Infusion. Cycle 2+ - Intravenous (IV) Infusion or Subcutaneous (SC) Administration.

Trial Locations (41)

10003

Hospital San Pedro de Alcantara, Cáceres

11702

New York Cancer & Blood Specialists - New Hyde Park, Babylon

11776

New York Cancer & Blood Specialists - Babylon Medical Oncology, Port Jefferson

15121

Ospedaliera Santi Antonio E Biagio E Cesare Arrigo-SC Ematologia, Alessandria

19611

Reading Hospital - Tower Health, Reading

20122

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

20155

USOR - Virginia Cancer Specialists - Gainesville Office, Gainesville

23229

Virginia Cancer Institute - West End, Richmond

23456

USOR - Virginia Oncology Associates, Virginia Beach

24060

Blue Ridge Cancer Care - Blacksburg, Blacksburg

25123

Azienda Socio Sanitaria Territoriale (ASST) degli Spedali Civili di Brescia, Brescia

28034

Hospital Universitario Ramón y Cajal, Madrid

28040

Hospital Universitario Fundación Jiménez Díaz, Madrid

28204

Novant Health Cancer Specialists - Charlotte, Charlotte

29605

Prisma Health Cancer Institute, Greenville

31008

Clinica Universidad de Navarra - Pamplona, Pamplona

39008

Hospital Universitario Marqués de Valdecilla, Santander

41501

Leonard Lawson Cancer Center, Pikeville

43210

Ohio Health - Research and Innovation Institute, Columbus

44106

University Hospitals Cleveland Medical Center, Cleveland

45236

USOR - Oncology Hematology Care - Kenwood, Cincinnati

46015

Hospital Arnau de Vilanova, Valencia

57105

Avera Cancer Institute, Sioux Falls

60714

USOR - Illinois Cancer Specialists - Niles, Niles

72205

Winthrop P. Rockefeller Cancer Institute, Little Rock

75230

Texas Oncology - Medical City Dallas, Dallas

75231

USOR - Texas Oncology - Presbyterian Cancer Center Dallas, Dallas

75246

USOR - Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas

75702

Texas Oncology Northeast Texas - Tyler, Tyler

77030

University of Texas MD Anderson Cancer Center, Houston

78240

USOR - Texas Oncology - San Antonio, San Antonio

78705

Texas Oncology - Austin Midtown, Austin

80012

Rocky Mountain Cancer Centers - Aurora, Aurora

85724

University of Arizona Cancer Center, Tucson

89511

Cancer Care Specialists - Nevada, Reno

97401

Willamette Valley Cancer Institute and Research Center - Eugene, Eugene

98684

USOR - Northwest Cancer Specialists, P.C. dba Compass Oncology - Vancouver Cancer Center, Vancouver

99352

Kadlec Clinic - Hematology and Oncology, Richland

00919-1227

Hospital Español Auxilio Mutuo, San Juan

08003

Hospital del Mar - Parc de Salut Mar, Barcelona

08908

Institut Català d'Oncologia - Hospital Duran i Reynals (ICO L'Hospitalet), Barcelona

Sponsors
All Listed Sponsors
lead

ADC Therapeutics S.A.

INDUSTRY